Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Trillium Therapeutics Inc. (TRIL)

4.18   0.02 (0.48%) 02-21 16:00
Open: 4.18 Pre. Close: 4.16
High: 4.45 Low: 3.92
Volume: 3,130,364 Market Cap: 309M
Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.45 - 4.466 4.466 - 4.48
Low: 3.88 - 3.898 3.898 - 3.914
Close: 4.15 - 4.176 4.176 - 4.201

Technical analysis

as of: 2020-02-21 4:34:30 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.68     One year: 6.63
Support: Support1: 3.28    Support2: 2.30
Resistance: Resistance1: 4.86    Resistance2: 5.68
Pivot: 3.81
Moving Average: MA(5): 3.84     MA(20): 3.95
MA(100): 1.40     MA(250): 0.84
MACD: MACD(12,26): 0.34     Signal(9): 0.42
Stochastic oscillator: %K(14,3): 57.31     %D(3): 37.65
RSI: RSI(14): 64.46
52-week: High: 4.86  Low: 0.24  Change(%): 470.3
Average Vol(K): 3-Month: 431730  10-Days: 173232

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
TRIL has closed below upper band by 6.5%. Bollinger Bands are 7.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 27 Jan 2020 18:22:00 +0000
This Cancer Drug Is Driving Forty Seven's Stock Higher

Fri, 03 Jan 2020 02:49:58 +0000
DRRX Plunges On Psoriasis Trial Data, INCY Fails GRAVITAS-301 Test, AGRX Abuzz

Tue, 20 Mar 2018 12:51:53 +0000
Health Care Sector Update for 03/20/2018: CRME, KMPH, AFMD, TRIL, MDT

Wed, 03 Feb 2016 13:52:10 +0000
Health Care Sector Update for 02/03/2016: TRIL, MRK

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 74.97
Shares Float (M) 22.60
% Held by Insiders 0.20
% Held by Institutions 85.97
Shares Short (K) 789
Shares Short P. Month (K)

Stock Financials

EPS -2.548
Book Value (p.s.) 0.090
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -52.9
Return on Equity (ttm) -103.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -1.64
P/E Growth Ratio
P/BV 46.44
P/S
P/CF

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-11-19
Last Split Ratio 0.033
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.